Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism

Elvin Koh(National University of Singapore), Matthew Wook Chang(National University of Singapore)
Nature Communications
July 4, 2022
10.1038/s41467-022-31334-z
Cited by 109

Related Papers

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
|Nature Communications|2017|459
Engineered commensals for targeted nose-to-brain drug delivery
|Cell|2025|83
Confronting risks of mirror life
|Science|2024|80
Targeted Approaches for In Situ Gut Microbiome Manipulation
|Genes|2018|67
Engineered microbial systems for advanced drug delivery
|Advanced Drug Delivery Reviews|2022|65